Stay updated on Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial

Sign up to get notified when there's something new on the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    This updates the displayed revision/version indicator for the page from **v3.5.2** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-25T05:13:22.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T23:53:09.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Footer revision label updated to v3.5.0. The previous v3.4.3 label was removed.
    Difference
    0.1%
    Check dated 2026-03-20T00:48:10.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:29:41.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:23:58.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1; the visible content and functionality of the page appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:10:22.000Z thumbnail image

Stay in the know with updates to Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page.